SCHEMBL4892354

SCHEMBL4892354

CCCCCCCCCC[CH]Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.52
THRB P10828 1/20 0.50
FAAH O00519 3/20 0.46
TRPV1 Q8NER1 1/20 0.46
DNM1 Q05193 3/20 0.45
ALDH1A1 P00352 1/20 0.45
EP300 Q09472 1/20 0.41
GMNN O75496 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
APEX1 P27695 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614356 1.00
SCHEMBL4892754 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL7549110 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL4464561 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL613389 1.00
SCHEMBL2008106 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL4887747 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL10430519 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL8752644 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL10430512 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218728-B Invisible fingerprint coating and forming method thereof NBD纳米技术公司 2024-04-26 CN claimed
CN-117241670-A Antimicrobial surfaces and related methods 汉高股份有限及两合公司 2023-12-15 CN claimed
CN-112218728-A Invisible fingerprint coating and forming method thereof NBD纳米技术公司 2021-01-12 CN claimed
US-20080119493-A1 5,6-Dialkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds BASF AKTIENGESELLSCHAFT (DE) 2008-05-22 US claimed
EP-1725563-A2 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-11-29 EP claimed
WO-2005087770-A2 5,6-DIHYDROCARBYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2005-09-22 WO claimed
EP-4400551-A1 INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME Henkel AG & Co. KGaA (DE) 2024-07-17 EP disclosed
EP-3931269-B1 INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME HENKEL AG & CO KGAA (DE) 2024-06-26 EP disclosed
CN-112218728-B Invisible fingerprint coating and forming method thereof NBD纳米技术公司 2024-04-26 CN disclosed
CN-111440607-B Quantum dot with ionic liquid bonded by ions and preparation method thereof 新亚T&C公司 2024-04-19 CN disclosed
CN-117241670-A Antimicrobial surfaces and related methods 汉高股份有限及两合公司 2023-12-15 CN disclosed
EP-3022206-B1 EPHA4 INHIBITORS AS NEUROPROTECTIVE AGENTS UNIV HONG KONG SCIENCE & TECH (HK) 2023-07-12 EP disclosed
EP-3931269-A1 INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME NBD Nanotechnologies, Inc. (US) 2022-01-05 EP disclosed
EP-1725563-A2 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-11-29 EP disclosed
WO-2006092414-A1 5,6-DIALKYL-7-AMINO-AZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-09-08 WO disclosed
WO-2005087770-A2 5,6-DIHYDROCARBYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2005-09-22 WO disclosed
EP-0882768-B1 Method for producing of phthalocyanine compound NIPPON CATALYTIC CHEM IND (JP) 2001-12-19 EP disclosed
US-6034236-A REACTING A PHTHALONITRILE WITH A METAL OXIDE IN PRESENCE OF A SULFONIC ACID CATALYST NIPPON SHOKUBAI CO., LTD. (JP) 2000-03-07 US disclosed
EP-0882768-A2 Method for producing of phthalocyanine compound NIPPON SHOKUBAI CO., LTD. (JP) 1998-12-09 EP disclosed
EP-0385692-A2 Optcally active compounds SANYO CHEMICAL INDUSTRIES LTD. (JP) 1990-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119493-A1 5,6-Dialkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds DPM1, ALKBH5, DERA TSHR 3758/4885THRB 3385/4885FAAH 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.